Product Description
Abstract:Benign prostatic hyperplasia (BPH) is a very common condition in older men, affecting up to 80% of men aged ≥ 80 years in the United States. It typically leads to lower urinary tract symptoms, which often require medical management. The exact cause of BPH is unknown, and the only 2 established factors associated with BPH are age and the presence of androgens. Although the presence of testosterone is required for the development of BPH, testosterone is not thought to be the underlying factor causing BPH because testosterone levels decrease in older men. Recent studies have reported that BPH is associated with elevations in plasma estradiol/testosterone ratio, insulin, and insulin-like growth factor-I. Daily aerobic exercise can reduce all of these plasma factors, particularly when combined with a low-fat, high-fiber diet consisting of whole grains, fruits, and vegetables. In cell culture studies, this type of lifestyle regimen has recently been shown to reduce the growth of serum-stimulated prostate epithelial cells and the growth of androgen-dependent prostate cancer cell lines. ... Read more

Product Description
Abstract: The prostate is a walnut-sized gland that is part of the male reproductive system. It is located below the bladder (the organ that stores urine) and surrounds the top portion of the tube that carries urine out of the body (the urethra). The prostate gland makes fluid for semen, which transports sperm during ejaculation.

In most men, the prostate gland begins to gradually enlarge after about age 40. The reasons for this are not entirely clear, but hormone changes seem to be a factor. The enlargement is called benign prostatic hyperplasia (BPH), and it affects more than half of men over age 60 and about 80% of those over 80. However, only about half these men have any symptoms. ... Read more

Product Description
Each of the 41 case studies presented puts the patient and his symptoms into context, describing the urological history and results of physical examinations, presenting the patient's voiding diary, and depicting the results of a variety of different urodynamic examinations with the use of traces and photographs. Didactic analyses of the data by Dr Blaivas at the end of each study give the reader instruction and a solid basis for further discussion and consideration of future clinical trials. Case Studies in Benign Prostatic Hyperplasia is an essential addition to the libraries of all medical professionals engaged in the research and treatment of men suffering from LUTS, urologists-in-training and urological specialists. ... Read more

Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on August 15, 2002. The length of the article is 555 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Finasteride and doxazosin combo halts BPH progress in 67%. (Results of Mtops Trial).(benign prostatic hyperplasia)
Author: Michele G. Sullivan
Publication: Internal Medicine News (Magazine/Journal)
Date: August 15, 2002
Publisher: International Medical News Group
Volume: 35Issue: 16Page: 6(1)

Distributed by Thomson Gale ... Read more

Product Description
5th International Consultation on Benign Prostatic Hyperplasia (BPH) June 25-28, 2000 Paris; World Health Organization (WHO) International Union Against Cancer (UICC) ... Read more

Product Description
This volume is produced from digital images created through the University of Michigan University Library's large-scale digitization efforts. The Library seeks to preserve the intellectual content of items in a manner that facilitates and promotes a variety of uses. The digital reformatting process results in an electronic version of the original text that can be both accessed online and used to create new print copies. The Library also understands and values the usefulness of print and makes reprints available to the public whenever possible. This book and hundreds of thousands of others can be found in the HathiTrust, an archive of the digitized collections of many great research libraries. For access to the University of Michigan Library's digital collections, please see http://www.lib.umich.edu and for information about the HathiTrust, please visit http://www.hathitrust.org ... Read more

Product Description
This Handbook on BPH aims to inform clinicians about the cause of a significant reduction in the quality of life for many millions of men worldwide. This clinically comprehensive and easy-to-assimilate handbook provides doctors with the necessary tools for diagnoses and effective treatment options. Illustrations and charts provide further detailed information to readers.Well- respected clinicians from several countries have contributed their expertise in developing this informative publication.Some of the areas covered are:The etiology of BPH, Diagnostic steps, What is LUTS?, Pharmacological treatment options, Minimally invasive treatments, Surgical interventions, treatment outcomes and care of the BPH patient, and Future Outlook in the treatment of BPH ... Read more

Product Description
This digital document is an article from Environmental Health Perspectives, published by Thomson Gale on November 1, 2006. The length of the article is 7626 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Serum dioxin, testosterone, and subsequent risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans.(Research)(Clinical report)
Author: Amit Gupta
Publication: Environmental Health Perspectives (Magazine/Journal)
Date: November 1, 2006
Publisher: Thomson Gale
Volume: 114Issue: 11Page: 1649(6)

Article Type: Clinical report

Distributed by Thomson Gale ... Read more

Product Description
Educational service to physicians in association with the International Prostate Health Council. ... Read more

Product Description
This digital document is an article from Family Practice News, published by International Medical News Group on August 15, 2002. The length of the article is 619 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Finasteride, doxazosin combo reduces progression of BPH. (Results of Multicenter Trial).(benign prostatic hyperplasia)
Author: Michele G. Sullivan
Publication: Family Practice News (Magazine/Journal)
Date: August 15, 2002
Publisher: International Medical News Group
Volume: 32Issue: 16Page: 20(1)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on October 1, 2002. The length of the article is 1486 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Urologix benign prostatic hyperplasia patent lawsuit dismissed.
Publication: BIOTECH Patent News (Newsletter)
Date: October 1, 2002
Publisher: Biotech Patent News
Volume: 16Issue: 10

Distributed by Thomson Gale ... Read more

Product Description
Chapters: 5-Alpha-Reductase Inhibitors, Alpha Blockers, Mirtazapine, Finasteride, Yohimbine, Dutasteride, Prazosin, Corynanthine, Tamsulosin, Ajmalicine, Phentolamine, Alpha-1 Blocker, Sb-269,970, Phenoxybenzamine, Silodosin, Doxazosin, L-765,314, Imiloxan, Idazoxan, Alfuzosin, Alpha-2 Blocker, Terazosin, Bunazosin, Nan-190, Indoramin, Abanoquil, Brl-44408, Dapiprazole, Fce 28260. Source: Wikipedia. Pages: 102. Not illustrated. Free updates online. Purchase includes a free trial membership in the publisher's book club where you can select from more than a million books without charge. Excerpt: Mirtazapine (Remeron, Avanza, Zispin, Reflex) is a tetracyclic antidepressant (TeCA) used primarily in the treatment of depression. It is also sometimes used as an anxiolytic, hypnotic, antiemetic, appetite stimulant, and antihistamine, among other indications. Along with its close analogues mianserin and setiptiline, mirtazapine is one of the few noradrenergic and specific serotonergic antidepressants (NaSSAs). Esmirtazapine, the (S)-(+)-enantiomer of mirtazapine, is currently under development for the treatment of insomnia and menopausal symptoms by the same company that produced mirtazapine. Mirtazapine was introduced by Organon International in the United States in 1990 for the treatment of depression. It quickly spread throughout most of the rest of the world as well and became a widely used antidepressant, particularly for those desiring to gain weight. Mirtazapine's primary use is the treatment of moderate to severe clinical depression. Mirtazapine has been found to be useful in the treatment of generalized anxiety disorder (GAD), social anxiety disorder (SAD) or social phobia (SP), obsessive-compulsive disorder (OCD), panic disorder (PD), post-traumatic stress disorder (PTSD), seasonal affective disorder (SAD), insomnia, nausea and vomiting (emesis), loss of appetite or anorexia and subsequent unintentional weight loss,, and it...More: http://booksllc.net/?id=527555 ... Read more

Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on August 15, 2002. The length of the article is 600 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Dutasteride cuts BPH symptoms, PSA level, prostate volume. (Inhibits Type I, II Isoenzymes).(benign prostatic hyperplasia)
Publication: Internal Medicine News (Magazine/Journal)
Date: August 15, 2002
Publisher: International Medical News Group
Volume: 35Issue: 16Page: 6(1)

Distributed by Thomson Gale ... Read more